Skip to content

Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia

Hammersmith Hospital Patients With Pulmonary Arteriovenous Malformations (PAVMs) and Hereditary Haemorrhagic Telangiectasia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00230685
Enrollment
2000
Registered
2005-10-03
Start date
2000-01-31
Completion date
2028-01-31
Last updated
2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Telangiectasia, Hereditary Hemorrhagic

Keywords

Pulmonary arteriovenous malformations

Brief summary

This observational study is for individuals with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that are reviewed at the Hammersmith Hospital, London.

Detailed description

The Hammersmith Hospital provides a clinical service for patients with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that is unique in the United Kingdom. Measurements obtained as part of standard clinical practice that has evolved since 1985 allow us to assess whether particular groups of individuals that we see are more prone to recognised complications such as strokes, brain abscesses, pregnancy related complications or pulmonary hypertension. We hypothesise that certain clinical characteristics will predict the susceptibility of individuals to particular complications.

Interventions

None listed

Sponsors

The Margaret Hayton HHT Fund
CollaboratorUNKNOWN
Imperial College London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients attending Hammersmith Hospital

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
StrokeProspectiveIschaemic stroke attributable to PAVMs
Venous thromboemboli (VTE)ProspectiveVTE of any origin

Countries

United Kingdom

Contacts

Primary ContactClaire L Shovlin
c.shovlin@imperial.ac.uk0208 383 1000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026